Skip to content

Author

R. Cannella

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

LAFOV PSMA PET/CT: Preliminary Report on Protocol Optimization and Future Perspectives in Prostate Cancer Imaging

Long axial field-of-view (LAFOV) PET/CT systems provide up to 40-fold higher sensitivity than standard digital systems. This study evaluated the impact of reducing acquisition times in [18 F]DCFPyL (PSMA) total-body PET/CT to support future research on the development of low-dose protocols. Eighty-five patients with prostate cancer underwent total-body PET/CT on a 194 cm-LAFOV system. Standard 8-minute list-mode acquisitions were retrospectively reconstructed into 6-, 4-, and 2-minute datasets. In a subgroup of thirty-three consecutive patients, two experts independently assessed image quality (5-point Likert scale) and E-PSMA criteria. Quantitative analysis (SUVmax, SUVmean) was performed for primary, nodal, and bone lesions. In the whole dataset ( n  = 85) the lesion detection rate (90.5%) and classification consistency between readers and across acquisition times exceeded 95% and remained stable between the 8-minute and 2-minute reconstructions. In a sub-group of thirty-three, no significant differences were found in quantitative parameters across all acquisition times ( p  > 0.05). While image quality scores improved slightly with longer durations (ranging from 4.50 at 2 min to 4.82 at 8 min), lesion visibility remained high even at 2 min. Changes in physiological background uptake did not impact lesion quantification. The preliminary results of the study suggest that LAFOV-PSMA-PET/CT preserves quantitative accuracy and lesion detectability even with acquisition times reduced to 2–4 min. These findings demonstrate that high-sensitivity systems might significantly shorten protocols without compromising diagnostic integrity, providing a potential rationale for further optimization of imaging protocols and for future prospective studies specifically designed to evaluate whether the administered radiotracer activity can be safely reduced to ultra-low-dose levels while maintaining diagnostic performance.

P. Alongi, A. Comelli, S. Morea et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.